Nuremberg 1586 - 1642. Epidural analgesia is preferred. Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Recommendations on pre‐hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine, 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy, A management algorithm for acute heart failure in pregnancy. König writes, for example, about opening his gallery with a show by the artist Michaela Meise. ACE, angiotensin‐converting enzyme; ARB, angiotensin receptor blocker; b.i.d., twice daily; HF, heart failure; ICU, intensive care unit; LVEF, left ventricular ejection fraction; MCS, mechanical circulatory support; MRA, mineralocorticoid receptor antagonist; o.d., once daily; RV, right ventricular; SBP, systolic blood pressure. Elevated prolactin levels have been associated with poor outcome in patients receiving ECMO support.77 Individualized bromocriptine treatment with dose up‐titration until successful prolactin suppression is achieved is a possible therapeutic option in these highly selected cases.59 The safety profile seems reasonable when at least prophylactic anticoagulation is administered.59. Many drugs, including ACE inhibitors, beta‐blockers and MRAs, pass into human breast milk but this is often at clinically insignificant levels (see online supplementary Table S1). In his book, König calls this one of his ‘favourite exhibitions from the early years of my gallery’. By contrast, HHFP patients were more likely to have a family history of hypertension, hypertension and pre‐eclampsia in a previous pregnancy, tachycardia at presentation, and LV hypertrophy. St. Agnes outside view. Kito Nedo lives in Berlin where he works as contributing editor for frieze and as freelance journalist for several magazines and newspapers. Mortality was 17% in PPCM compared to 0% among HHFP. Cardiomyopathies are not very common diseases, but may cause severe complications, making a substantial contribution to maternal morbidity and mortality during pregnancy, in the immediate peripartum period, and up to months later.1 Peripartum cardiomyopathy (PPCM) has to be differentiated from other causes of heart failure. By continuing to browse this site, you agree to its use of cookies as described in our, I have read and accept the Wiley Online Library Terms and Conditions of Use, Late maternal deaths: a neglected responsibility, EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM, Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM, Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy, Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy, Current state of knowledge on Takotsubo syndrome: a position statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology, Takotsubo syndrome after cesarean section: rare but possible, Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population‐based study, Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy‐Associated Cardiomyopathy), Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non‐African American women, Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy, Peripartum cardiomyopathy in Denmark: a retrospective, population‐based study of incidence, management and outcome, Peripartum cardiomyopathy: current management and future perspectives, Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders.